(833) 317-6278
Book a Demo
Gene Tx
Gray shield icon
Is this you?
Claim your profile.

Gene Tx

AS SEEN ON
Endpoints News, NewsBreak

Preston's Summary

Gene Tx is a journalist who writes for Endpoints News, a leading source for biotech and pharmaceutical news. With a focus on the latest developments in the industry, Gene covers a wide range of topics including clinical trials, gene editing, IPOs, and regulatory updates. Gene's expertise lies in providing insightful and timely reporting on the ever-evolving world of biotechnology.

Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston

Geo Focus

Coverage Attributes:

Beta
Press Release: 45 %
Private Sector Announcements: 18 %
Cites Data: 13 %
Government Announcement: 6 %
Industry Specific: 4 %

Themes Covered:

Most Recent Topics:

  • Biotechnology
  • Gene Therapy
  • Hematology
  • Immunology
  • Oncology
  • FDA

Pitching Insights

Gene Tx's coverage centers around gene therapy, biotech, and healthcare & pharmaceutical industry. The majority of the articles are comprised of press releases and private sector announcements, with a significant emphasis on FDA approvals and clinical trials.

If reaching out to Gene Tx, consider providing insights or access to exclusive data related to gene therapy companies, FDA regulatory affairs within the biotech space, IPOs in the healthcare sector or detailed analysis of clinical trial results in these areas. Additionally, sources with insider knowledge into private sector developments such as mergers/acquisitions would likely be valuable for this journalist's coverage.

Due to Gene Tx's focus on these specific topics within the broader realm of healthcare and pharmaceuticals, pitches should align closely with these themes while offering unique perspectives or newsworthy information relevant to ongoing trends in gene therapy and biotechnology industries.

This information evolves through artificial intelligence and human feedback. Improve this profile .

Journalists With Similar Coverage:

Based on similarity of content.
Paul Schloesser

Paul Schloesser

Associate Editor
Publications
Endpoints News
Most recent topics
Healthcare & Pharmaceutical, Biotechnology, Scientific, Product Promotions, Sales & Marketing
Amber Tong

Amber Tong

Senior Editor
****r@**************com
Publications
Endpoints News
Most recent topics
Healthcare & Pharmaceutical, Biotechnology, Content & Publishing, Scientific, Sales & Marketing
Jason Mast

Jason Mast

Reporter
********st@**********om
Publications
STAT, Boston Globe Technology, everand.com
Most recent topics
Healthcare & Pharmaceutical, Scientific, Health, Biotechnology, Business
Max Gelman

Max Gelman

Senior Editor
**x@**************com
Publications
Endpoints News, NewsBreak
Most recent topics
Healthcare & Pharmaceutical, Biotechnology, Scientific, Data & Analytics, Sales & Marketing
Lei Lei Wu

Lei Lei Wu

News Reporter
**u@**************com
Publications
Endpoints News
Most recent topics
Healthcare & Pharmaceutical, Biotechnology, Scientific, Product Promotions, Content & Publishing
Ayisha Sharma

Ayisha Sharma

Biopharma Breaking News Reporter
******a@********om
Publications
Endpoints News, fitandwell.com, NewsBreak
Most recent topics
Healthcare & Pharmaceutical, Data & Analytics, Biotechnology, Sales & Marketing, Scientific

Articles

© 2024 Intelligent Relations